| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 10/28/2004 | WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | WO2004080379A3 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect |
| 10/28/2004 | WO2004073612A3 Estrogen receptor modulators |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/27/2004 | CN1541215A HIV inhibiting pyrimidines derivatives |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541203A 4-(phenyl-(piperidin-4-YL)-amino)-benzamide derivatives and their use for treatment of pain, anxiety or gastrointestinal disorders |
| 10/27/2004 | CN1541096A Compounds which mimic chemical and biological properties of discodermolide |
| 10/27/2004 | CN1539825A Compounds useful to treat retroviral infections |
| 10/27/2004 | CN1172930C PDE IV inhibiting pyridine derivatives |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004089925A1 Pi-3 kinase inhibitor prodrugs |
| 10/21/2004 | US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 10/21/2004 | US20040209825 Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto |
| 10/21/2004 | CA2518916A1 Pi-3 kinase inhibitor prodrugs |
| 10/20/2004 | EP1467726A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | CN1538841A C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 10/19/2004 | US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects |
| 10/14/2004 | WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 10/14/2004 | WO2004087687A1 Chromene derivatives as anti-inflammatory agents |
| 10/14/2004 | WO2004087686A2 Benzopyran compounds useful for treating inflammatory conditions |
| 10/14/2004 | WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
| 10/14/2004 | US20040204477 For use as antiproliferative agents |
| 10/14/2004 | US20040204462 E.g., l2-{3-[2-(4-Fluorophenyl)oxazol-4-ylmethoxy]cyclohexyloxy}-6-methylbenzoic acid; lipid- and/or triglyceride-lowering properties; metabolic disorders; antidiabetic agents (type II); therapy of syndrome X; eating disorders; cardiomyopathy |
| 10/14/2004 | CA2520896A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 10/14/2004 | CA2520724A1 Benzopyran compounds useful for treating inflammatory conditions |
| 10/14/2004 | CA2519291A1 Chromene derivatives as anti-inflammatory agents |
| 10/13/2004 | CN1537108A Iodobenzopyrran-4-one derivatives having fungicidal activity |
| 10/13/2004 | CN1170827C Benzofurylpyrone deriuvatives |
| 10/12/2004 | US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc |
| 10/07/2004 | WO2004085344A2 Production of oxy-michael adducts |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198808 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/06/2004 | EP1465020A2 Organophotoreceptor with a charge transport compound having an epoxy group |
| 10/06/2004 | EP1463726A2 Aromatic thioether liver x-receptor modulators |
| 10/06/2004 | EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | CN1169798C Novel diazo alcoholic antifungal compound and its preparing process |
| 10/05/2004 | US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | US20040192944 14-Hydrido-9beta-hydroxytetracyclic taxanes |
| 09/30/2004 | US20040192767 EP4 receptor antagonists |
| 09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |
| 09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192672 Iodobenzopyran-4-one derivatives having fungicidal activity |
| 09/29/2004 | EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/28/2004 | US6797833 Taxane derivatives having a tricyclic or tetracyclic core; remarkable properties in vitro; valuable antileukemia, antitumor and anticarcinogenic agents; human cancer cell line comparable to that of taxol and taxotere |
| 09/23/2004 | WO2004080990A1 C-glycoside derivatives and salts thereof |
| 09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | WO2004080379A2 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect |
| 09/23/2004 | WO2004030684A3 Kavalactone product |
| 09/23/2004 | US20040186287 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 09/23/2004 | US20040186170 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 09/23/2004 | US20040186165 action similar to Taxol but it is active against Taxol-resistant cell lines and it is more water soluble; anticarcinogenic |
| 09/23/2004 | US20040186125 E.g , 3-cyclohexyl-2-furan-3-yl-1Hindole-5-carboxylic acid; hepatitis C viricides that target RNA dependent RNA polymerases (Ns5B) in mammals, an enzyme essential to viral replication; used in conjunction with an mmunomodulatory agent, such as beta -, delta - gamma -, and omega -interferon |
| 09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/22/2004 | EP1458703A1 Isochroman compounds for treatment of cns disorders |
| 09/22/2004 | EP1458381A1 Triazoles as oxytocin antagonists |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | CN1530365A Heterocyclic substituted 2,5-pyrroline photochromic copmounds and synthesis and use thereof |
| 09/22/2004 | CN1167686C Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds |
| 09/21/2004 | US6794523 Anticancer agents, antitumor agents; leukemia |
| 09/16/2004 | WO2004078750A1 Tetrahydropyran compounds as tachykinin antagonists |
| 09/16/2004 | WO2004037211A3 Taxane metabolites |
| 09/16/2004 | US20040181067 Tri(cyclo) substituted amide compounds |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | CA2517422A1 Tetrahydropyran compounds as tachykinin antagonists |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1455769A2 Processes for preparing crystalline and amorphous mupirocin calcium |
| 09/15/2004 | CN1166659C Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites |
| 09/15/2004 | CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors |
| 09/10/2004 | WO2004075863A2 Cxcr3 antagonists |
| 09/10/2004 | WO2004075853A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 09/10/2004 | WO2004075815A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | CA2516573A1 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | CA2515842A1 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 09/09/2004 | US20040176610 Indolone oxazolidinones and derivatives thereof |
| 09/09/2004 | US20040176443 Capsaicin receptor ligands |
| 09/09/2004 | US20040176440 compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction; cancer, tumour growth, arteriosclerosis, age-related macular degeneration, diabetic retinopathy, inflammatory diseases and the like |
| 09/08/2004 | EP1453827A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 09/08/2004 | EP0785782B1 Use of disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid-like activity |
| 09/08/2004 | CN1527818A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1165531C Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenedimine group |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/02/2004 | WO2004074282A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
| 09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | WO2004074262A1 Hiv replication inhibiting pyrimidines and triazines |
| 09/02/2004 | WO2004074261A1 Hiv replication inhibiting pyrimidines and triazines |
| 09/02/2004 | WO2004073612A2 Estrogen receptor modulators |
| 09/02/2004 | US20040171873 Process for the preparation of 17-phenyl-18,19,20-thinor-pgf 2a and its derivatives |